Mbb Public Markets I »

Allogene Therapeutics shares owned by Mbb Public Markets I

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Mbb Public Markets I from 13F filings

Historical chart of Mbb Public Markets I investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Mbb Public Markets I consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Mbb Public Markets I

Quarter filed Position value Share count Share price at filing
2023-12-31 $184k 57k 3.21
2023-09-30 $182k 57k 3.17
2023-06-30 $426k 86k 4.97
2023-03-31 $265k 54k 4.94

More positions owned by Mbb Public Markets I

Select Sector Spdr Tr Sbi Healthcare (XLV)
Teck Resources CL B Call Option (TECK)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Call Option (RSP)
Ishares Msci Brazil Etf Call Option (EWZ)
Vanguard Index Fds Value Etf (VTV)
Bunge Global Sa Com Shs (BG)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Humana Call Option (HUM)
Spdr Ser Tr S&p Biotech Call Option (XBI)
Freeport-mcmoran CL B Call Option (FCX)
Ishares Msci Jpn Etf New Call Option (EWJ)
UnitedHealth (UNH)
Bank of America Corporation (BAC)
CF Industries Holdings (CF)
Dimensional Etf Trust Internatnal Val (DFIV)

View all positions for Mbb Public Markets I

Top funds holding Allogene Therapeutics

Tpg Gp A
Vanguard Group
Jpmorgan Chase & Co
PRIMECAP Management Company
Citadel Advisors
Goldman Sachs Group
T. Rowe Price Associates
Two Sigma Investments
Millennium Management
Vida Ventures Advisors
Dimensional Fund Advisors
Two Sigma Advisers
Caxton Associates
Nordea Investment Management Ab
Charles Schwab Investment Management

View all funds holding Allogene Therapeutics